sizofiran has been researched along with picibanil in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gorai, I; Minaguchi, H; Yanagibashi, T | 1 |
| Asakawa, M; Horii, A; Kyo, M; Maekawa, M; Yasumoto, R | 1 |
| Hamazaki, Y; Noda, K; Okamura, K; Yajima, A | 1 |
| Itoh, H; Kitajima, M; Seki, M; Tachikawa, I; Watanabe, Y; Yagita, A | 1 |
| Hosaka, N; Itoh, H; Matsumoto, H; Oda, T; Okada, N; Ono, M; Ootsuka, S; Orima, I; Takeuchi, N; Yagita, A | 1 |
| Akasaka, Y; Amamiya, K; Fujimoto, S; Hosaka, K; Inokuchi, H; Kawai, K; Sugimoto, H; Susuki, H; Tanaka, Y; Uozumi, G | 1 |
| Ishida, N; Matsubara, S; Suzuki, F; Suzuki, M | 1 |
| Chihara, G; Hamuro, J; Maeda, YY | 1 |
| Kurokawa, T; Tamakuma, S | 1 |
| Noda, K; Okamura, K; Yajima, A | 1 |
1 review(s) available for sizofiran and picibanil
| Article | Year |
|---|---|
Current status and perspectives of immunomodulators of microbial origin.
Topics: Adjuvants, Immunologic; Animals; Bacteria; BCG Vaccine; Blood Proteins; Carbohydrate Conformation; Chemical Phenomena; Chemistry; Colonic Neoplasms; Fungi; Glucans; Humans; Immunotherapy; Infections; Lentinan; Lymphocytes; Macrophage Activation; Neoplasms, Experimental; Picibanil; Polysaccharides; Proteoglycans; Rectal Neoplasms; Sizofiran; Stomach Neoplasms; Structure-Activity Relationship | 1982 |
1 trial(s) available for sizofiran and picibanil
| Article | Year |
|---|---|
Adjuvant immunotherapy: two randomized controlled studies of patients with cervical cancer.
Topics: Biological Products; Clinical Trials as Topic; Female; Glycosaminoglycans; Humans; Neoplasm Staging; Picibanil; Random Allocation; Sizofiran; Uterine Cervical Neoplasms | 1989 |
8 other study(ies) available for sizofiran and picibanil
| Article | Year |
|---|---|
Immunological modulation of lymphocyte subpopulation in cervical cancer tissue by sizofiran and OK-432.
Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte; Carcinoma, Squamous Cell; CD3 Complex; CD4 Antigens; CD5 Antigens; CD8 Antigens; Female; Humans; Immunity; Immunohistochemistry; Lymphocyte Subsets; Middle Aged; Picibanil; Receptors, Antigen, T-Cell; Receptors, Fc; Receptors, IgG; Sizofiran; Uterine Cervical Neoplasms | 1992 |
Multidisciplinary treatment for bladder carcinoma--biological response modifiers and kampo medicines.
Topics: Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Combined Modality Therapy; Drugs, Chinese Herbal; Female; Humans; Immunologic Factors; Leucine; Male; Picibanil; Rats; Rats, Inbred Strains; Sizofiran; Urinary Bladder Neoplasms | 1991 |
[A long-term survivor of primary hepatoma--a case suggesting the superiority of a multi-drug (OK-432, SPG, PSK) over mono-drug immunotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Mitomycin; Mitomycins; Picibanil; Prognosis; Proteoglycans; Sizofiran | 1986 |
[A case report of patient with advanced stomach carcinoma of linitis plastica type responding to multi-immunotherapy and chemotherapy].
Topics: Adenocarcinoma, Scirrhous; Adult; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Carbazilquinone; Glycosaminoglycans; Humans; Male; Mitomycin; Mitomycins; Picibanil; Proteoglycans; Sizofiran; Stomach Neoplasms | 1987 |
[Determination of the effects of antineoplastic agents using a canine stomach--evaluation of an antineoplastic polysaccharide, schizophyllan (SPG)].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Animals; Antineoplastic Agents, Phytogenic; Dogs; Drug Evaluation, Preclinical; Female; Glycosaminoglycans; Male; Picibanil; Sizofiran; Stomach Neoplasms | 1983 |
The induction of viral inhibitor(s) in mice treated with biological and synthetic immunopotentiators.
Topics: Adjuvants, Immunologic; Animals; Dose-Response Relationship, Drug; Glycopeptides; Interferon Inducers; Interferons; Lentinan; Levamisole; Mice; Mice, Inbred Strains; Mycobacterium bovis; Picibanil; Poly I-C; Proteoglycans; Sizofiran | 1980 |
[Two cases of cancer with bone metastases treated with local therapy].
Topics: Adult; Bone Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Female; Humans; Injections, Intralesional; Male; Middle Aged; Picibanil; Radiotherapy Dosage; Sizofiran; Uterine Cervical Neoplasms | 1993 |
Adjuvant immunotherapy for cervical cancer. Two randomized controlled studies using OK-432 or sizofiran.
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Humans; Immunotherapy; Neoplasm Staging; Picibanil; Randomized Controlled Trials as Topic; Sizofiran; Survival Analysis; Uterine Cervical Neoplasms | 1989 |